Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction

PaperCitations, authors & open-access status

The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 47 citations, 2018 year and gold oa status.

47
Citations
2018
Year
gold
OA Status

Related on ScholarIQ

Longfei Dai
Author
Histone Deacetylase Inhibitors Research
Topic
Histone Deacetylase Inhibitors Research
Topic
Protein Degradation and Inhibitors
Topic
Cancer Mechanisms and Therapy
Topic
470M+ articles · free account